Published in Cardiovasc Res on January 01, 2002
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol (2003) 3.19
Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol (2003) 2.26
Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med (2006) 1.99
Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation (2010) 1.80
Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci (2005) 1.53
Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. Br J Pharmacol (2007) 1.33
Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev (2002) 1.16
Novel modulators of poly(ADP-ribose) polymerase. Trends Pharmacol Sci (2006) 1.12
Pathophysiological roles of peroxynitrite in circulatory shock. Shock (2010) 1.10
Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch (2007) 1.08
Peroxynitrite in myocardial ischemia-reperfusion injury. Heart Fail Rev (2002) 1.01
Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases. Cardiovasc Res (2012) 0.96
Inhibition of matrix metalloproteinase-2 by PARP inhibitors. Biochem Biophys Res Commun (2009) 0.95
Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol (2008) 0.94
Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. Br J Pharmacol (2007) 0.92
The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6. J Neuroinflammation (2015) 0.92
Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction. J Cell Mol Med (2010) 0.91
Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders. Biomol Ther (Seoul) (2012) 0.89
Myocardial contractile effects of nitric oxide. Heart Fail Rev (2002) 0.88
Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats. J Neurochem (2010) 0.88
Fibrosis in Atrial Fibrillation - Role of Reactive Species and MPO. Front Physiol (2012) 0.87
Modulation of myocardial contraction by peroxynitrite. Front Physiol (2012) 0.81
Chronic cardiotoxicity of doxorubicin involves activation of myocardial and circulating matrix metalloproteinases in rats. Acta Pharmacol Sin (2012) 0.80
Oxidative stress as a common mediator for apoptosis induced-cardiac damage in diabetic rats. Open Cardiovasc Med J (2008) 0.80
The effects of extracellular matrix proteins on neutrophil-endothelial interaction--a roadway to multiple therapeutic opportunities. Yale J Biol Med (2012) 0.79
Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). Curr Neuropharmacol (2014) 0.79
Ischemic postconditioning decreases matrix metalloproteinase-2 expression during ischemia-reperfusion of myocardium in a rabbit model: A preliminary report. Exp Clin Cardiol (2013) 0.79
Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release. Br J Pharmacol (2005) 0.78
Cardioprotective effects of voluntary exercise in a rat model: role of matrix metalloproteinase-2. Oxid Med Cell Longev (2015) 0.78
The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest (2017) 0.77
Inhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injury. Biomed Res Int (2014) 0.77
Intracellular regulation of matrix metalloproteinase-2 activity: new strategies in treatment and protection of heart subjected to oxidative stress. Scientifica (Cairo) (2013) 0.77
Low Frequency Electromagnetic Field Conditioning Protects against I/R Injury and Contractile Dysfunction in the Isolated Rat Heart. Biomed Res Int (2015) 0.77
Matrix metalloproteinase 2 contributes to pancreatic Beta cell injury induced by oxidative stress. PLoS One (2014) 0.76
Ischemic preconditioning: Interruption of various disorders. J Saudi Heart Assoc (2016) 0.75
Dynamic Alterations to α-Actinin Accompanying Sarcomere Disassembly and Reassembly during Cardiomyocyte Mitosis. PLoS One (2015) 0.75
Human Sperm Quality and Metal Toxicants: Protective Effects of some Flavonoids on Male Reproductive Function. Int J Fertil Steril (2016) 0.75
Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/MLCK-mediated cardiomyocyte protection from hypoxic injury. J Cell Mol Med (2016) 0.75
MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study. Biomed Res Int (2017) 0.75
Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial. Ann Intern Med (2006) 4.13
Long-term mortality and quality of life after prolonged mechanical ventilation. Crit Care Med (2004) 3.36
Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med (2002) 2.91
A motivational theory of life-span development. Psychol Rev (2010) 2.89
Effect of multicomponent interventions on caregiver burden and depression: the REACH multisite initiative at 6-month follow-up. Psychol Aging (2003) 2.70
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Review and meta-analysis of couple-oriented interventions for chronic illness. Ann Behav Med (2010) 2.47
The Resources for Enhancing Alzheimer's Caregiver Health (REACH): project design and baseline characteristics. Psychol Aging (2003) 2.36
Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol (2003) 2.26
Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation (2002) 2.25
The course of functional decline in older people with persistently elevated depressive symptoms: longitudinal findings from the Cardiovascular Health Study. J Am Geriatr Soc (2005) 2.20
Is it beneficial to involve a family member? A meta-analysis of psychosocial interventions for chronic illness. Health Psychol (2004) 2.14
Adaptive self-regulation of unattainable goals: goal disengagement, goal reengagement, and subjective well-being. Pers Soc Psychol Bull (2003) 2.13
Isolated heart perfusion according to Langendorff---still viable in the new millennium. J Pharmacol Toxicol Methods (2006) 2.06
Trust in the health care system and the use of preventive health services by older black and white adults. Am J Public Health (2008) 2.04
Family caregivers' strains: comparative analysis of cancer caregiving with dementia, diabetes, and frail elderly caregiving. J Aging Health (2008) 1.94
Prevalence and outcomes of caregiving after prolonged (> or =48 hours) mechanical ventilation in the ICU. Chest (2004) 1.91
Risk factors for potentially harmful informal caregiver behavior. J Am Geriatr Soc (2005) 1.81
Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation (2010) 1.80
Caregiving behavior is associated with decreased mortality risk. Psychol Sci (2009) 1.76
Caregiver-specific outcomes in antidementia clinical drug trials: a systematic review and meta-analysis. J Am Geriatr Soc (2005) 1.75
Effect of an in-home occupational and physical therapy intervention on reducing mortality in functionally vulnerable older people: preliminary findings. J Am Geriatr Soc (2006) 1.71
Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest (2002) 1.70
Preparedness for the death of a loved one and mental health in bereaved caregivers of patients with dementia: findings from the REACH study. J Palliat Med (2006) 1.69
Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J (2004) 1.69
Patient-specific, time-varying predictors of post-ICU informal caregiver burden: the caregiver outcomes after ICU discharge project. Chest (2009) 1.69
Benefit-finding in the cancer caregiving experience. Psychosom Med (2007) 1.67
Informal caregiver burden among survivors of prolonged mechanical ventilation. Am J Respir Crit Care Med (2006) 1.64
The association of race and socioeconomic status with cardiovascular disease indicators among older adults in the health, aging, and body composition study. J Gerontol B Psychol Sci Soc Sci (2002) 1.58
Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation (2005) 1.56
Interpersonal effects of suffering in older adult caregiving relationships. Psychol Aging (2009) 1.56
Depression and distress predict time to cardiovascular disease in dementia caregivers. Health Psychol (2007) 1.55
Caregiving at the end of life. J Palliat Med (2006) 1.54
Transitions in spousal caregiving. Gerontologist (2003) 1.54
Clinical research and the stages of dying. Omega (Westport) (1974) 1.53
Using a new taxonomy to combine the uncombinable: integrating results across diverse interventions. Psychol Aging (2003) 1.53
Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci (2005) 1.53
The Life Engagement Test: assessing purpose in life. J Behav Med (2006) 1.50
Financial exploitation and psychological mistreatment among older adults: differences between African Americans and non-African Americans in a population-based survey. Gerontologist (2010) 1.49
Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol (2003) 1.48
Patterns of depressive symptoms in caregivers of mechanically ventilated critically ill adults from intensive care unit admission to 2 months postintensive care unit discharge: a pilot study. Crit Care Med (2012) 1.45
Preparing family caregivers for death and bereavement. Insights from caregivers of terminally ill patients. J Pain Symptom Manage (2008) 1.42
The prognostic significance of inspiratory capacity in pulmonary arterial hypertension. Respiration (2014) 1.41
An evidence-based medicine elective course to improve student performance in advanced pharmacy practice experiences. Am J Pharm Educ (2011) 1.41
Postresuscitation administration of doxycycline preserves cardiac contractile function in hypoxia-reoxygenation injury of newborn piglets*. Crit Care Med (2014) 1.40
Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc Res (2009) 1.39
Prevalence and correlates of anxiety symptoms in well-functioning older adults: findings from the health aging and body composition study. J Am Geriatr Soc (2003) 1.38
Preparing caregivers for the death of a loved one: a theoretical framework and suggestions for future research. J Palliat Med (2006) 1.35
Positive and negative religious coping and well-being in women with breast cancer. J Palliat Med (2009) 1.34
Development of the risk appraisal measure: a brief screen to identify risk areas and guide interventions for dementia caregivers. J Am Geriatr Soc (2009) 1.33
Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med (2006) 1.33
Older spouses' perceptions of partners' chronic arthritis pain: implications for spousal responses, support provision, and caregiving experiences. Psychol Aging (2006) 1.32
A methodology for describing and decomposing complex psychosocial and behavioral interventions. Psychol Aging (2003) 1.32
Positive aspects of caregiving and adaptation to bereavement. Psychol Aging (2004) 1.28
Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem Pharmacol (2008) 1.28
Health stresses and depressive symptomatology in the elderly: the importance of health engagement control strategies. Health Psychol (2002) 1.27
Hospital costs in patients receiving prolonged mechanical ventilation: does age have an impact? Crit Care Med (2003) 1.26
Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res (2002) 1.23
Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol Heart Circ Physiol (2002) 1.23
Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation. FASEB J (2007) 1.23
Association of enjoyable leisure activities with psychological and physical well-being. Psychosom Med (2009) 1.22
Interventions to enhance physical and psychological functioning among younger women who are ending nonhormonal adjuvant treatment for early-stage breast cancer. J Clin Oncol (2005) 1.18
Guiding research in family care: a new approach to oncology caregiving. Psychooncology (2008) 1.16
Depressive symptoms in older African-American and white adults with functional difficulties: the role of control strategies. J Am Geriatr Soc (2007) 1.14
Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy. Circulation (2009) 1.13
Making sense of mild cognitive impairment: a qualitative exploration of the patient's experience. Gerontologist (2006) 1.12
Socioeconomic position and incident mobility impairment in the Cardiovascular Health Study. BMC Geriatr (2007) 1.10
Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol (2007) 1.09
Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc Res (2003) 1.08
Obstructive sleep apnea, oxidative stress and cardiovascular disease: lessons from animal studies. Oxid Med Cell Longev (2013) 1.07
Data and safety monitoring in social behavioral intervention trials: the REACH II experience. Clin Trials (2006) 1.07
Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med (2010) 1.07
Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. J Pharmacol Exp Ther (2005) 1.07
Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J Infect Dis (2008) 1.07
Religious beliefs and practices are associated with better mental health in family caregivers of patients with dementia: findings from the REACH study. Am J Geriatr Psychiatry (2006) 1.07
Spouses' cardiovascular reactivity to their partners' suffering. J Gerontol B Psychol Sci Soc Sci (2010) 1.05
Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart. Eur Heart J (2004) 1.05
Verbal communication among Alzheimer's disease patients, their caregivers, and primary care physicians during primary care office visits. Patient Educ Couns (2009) 1.05
Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion. Basic Res Cardiol (2008) 1.04
Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury. Circulation (2003) 1.04
Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder. Am J Geriatr Psychiatry (2005) 1.03
Physical health problems, depressive mood, and cortisol secretion in old age: buffer effects of health engagement control strategies. Health Psychol (2007) 1.02
Finding the best ways to help: opportunities and challenges of intervention research on aging. Gerontologist (2003) 1.02
Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Am J Respir Crit Care Med (2009) 1.01
Peroxynitrite in myocardial ischemia-reperfusion injury. Heart Fail Rev (2002) 1.01
Improving well-being in caregivers of terminally ill patients. Making the case for patient suffering as a focus for intervention research. J Pain Symptom Manage (2007) 1.00
What questions do family caregivers want to discuss with health care providers in order to prepare for the death of a loved one? An ethnographic study of caregivers of patients at end of life. J Palliat Med (2008) 1.00
Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease. Obstet Gynecol (2003) 1.00
Concurrent and long-term predictors of older adults' use of community-based long-term care services: the Caregiver Health Effects Study. J Aging Health (2004) 1.00
Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases. Pharmacol Res (2011) 1.00
Does who you marry matter for your health? Influence of patients' and spouses' personality on their partners' psychological well-being following coronary artery bypass surgery. J Pers Soc Psychol (2006) 1.00
Role of social support in predicting caregiver burden. Arch Phys Med Rehabil (2012) 0.98